Jennifer Buell - Jun 11, 2024 Form 3 Insider Report for AGENUS INC (AGEN)

Role
Chairman Executive Council, Director
Signature
Christine M. Klaskin, by Power of Attorney
Stock symbol
AGEN
Transactions as of
Jun 11, 2024
Transactions value $
$0
Form type
3
Date filed
6/20/2024, 04:05 PM
Previous filing
Mar 29, 2024
Next filing
Nov 18, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AGEN Common Stock 13.7K Jun 11, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding AGEN Stock Option, right to buy Jun 11, 2024 Common Stock 1.23K $100.80 Direct
holding AGEN Stock Option, right to buy Jun 11, 2024 Common Stock 525 $100.80 Direct
holding AGEN Stock Option, right to buy Jun 11, 2024 Common Stock 5K $83.20 Direct
holding AGEN Stock Option, right to buy Jun 11, 2024 Common Stock 6.25K $75.40 Direct
holding AGEN Stock Option, right to buy Jun 11, 2024 Common Stock 6.5K $41.40 Direct
holding AGEN Stock Option, right to buy Jun 11, 2024 Common Stock 15K $47.60 Direct
holding AGEN Stock Option, right to buy Jun 11, 2024 Common Stock 25K $82.40 Direct
holding AGEN Stock Option, right to buy Jun 11, 2024 Common Stock 500 $72.20 Direct
holding AGEN Stock Option, right to buy Jun 11, 2024 Common Stock 45K $74.00 Direct
holding AGEN Stock Option, right to buy Jun 11, 2024 Common Stock 45K $63.60 Direct F1
holding AGEN Stock Option, right to buy Jun 11, 2024 Common Stock 7.5K $64.40 Direct F2
holding AGEN Stock Option, right to buy Jun 11, 2024 Common Stock 37.5K $47.40 Direct F3
holding AGEN Stock Option, right to buy Jun 11, 2024 Common Stock 37.5K $11.80 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan (as amended) and vests over four years with one third vesting on the 2-year anniversary of the grant date (January 1, 2021) and the balance in equal quarterly installments thereafter.
F2 Options awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan (as amended) and vests over three years with one third vesting on the one year anniversary of the grant date (January 1, 2022) and the balance in equal quarterly installments thereafter.
F3 Options awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan (as amended) and vests over three years with one third vesting on the one year anniversary of the grant date (January 9, 2023) and the balance in equal quarterly installments thereafter.
F4 Options were granted on January 17, 2024 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 11, 2024. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on January 16, 2025 and the balance vesting in equal quarterly installments thereafter. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 750,000 Stock Options with an exercise price of $0.59..